tirzepatide microdose schedule Microdosing Chart: A Monthly Dose Guide For Josie Patients Microdosing Tirzepatide | AgelessRx

Take home message Wegovy isnt contraindicated in epilepsy, and emerging research suggests that GLP-1 receptor agonists may have neuroprotective properties

For global teams, Benepass advises on compliant weight health program design and administration across regions, helping employers apply a consistent strategy without losing local control

Accessed June 18th 2025

Because it targets three pathways, retatrutide is often referred to as a triple agonist. The glucagon receptor is the biggest difference between retatrutide and tirzepatide

Researchers are exploring its potential benefits in several fields, including heart disease, cardiovascular disease, non-alcoholic fatty liver disease, and even brain-related conditions